1/48
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Who conducted the first controlled clinical trial and what was it for?
Dr. James Lind in 1747; he tested 6 treatments for scurvy on 12 patients aboard HMS Salisbury and found oranges and lemons to be most effective
What was the significance of Ambroise Paré's 1537 experiment?
It was the first clinical trial of a novel therapy; he compared boiling oil vs. a mixture of egg yolks, rose oil, and turpentine for treating battle wounds
Who introduced the placebo in drug trials and when?
US physician Austin Flint in 1863; he used a dummy placebo remedy to treat 13 rheumatism patients and compared results to known active treatments
What was the first properly randomized double-blind placebo-controlled trial?
The 1948 Streptomycin trial for pulmonary tuberculosis
What disaster led to the Federal Food, Drug and Cosmetic Act of 1938?
The Sulfanilamide Disaster of 1937, where over 100 people died after the drug was dissolved in diethylene glycol (a toxic solvent)
What is the Nuremberg Code and what triggered it?
A set of 10 ethical principles for human experimentation, enacted in 1947 following the revelation of Nazi war crimes and inhumane medical experiments during WWII
Name two key principles highlighted by the Nuremberg Code
Voluntary consent and the right to stop participation
What drug caused over 10,000 birth defects including phocomelia and when was it withdrawn?
Thalidomide; withdrawn from the European market in 1961
What three regulatory outcomes followed the Thalidomide tragedy?
Committee on Safety of Drugs (1963), Medicines Act (1968), and Declaration of Helsinki
What was the Tuskegee Syphilis Experiment?
A 1932–1972 study where Black American men with syphilis were observed without treatment or informed consent, even after penicillin became available
What are the 3 core principles of the Belmont Report?
Respect for persons, Beneficence, and Justice
What are the 3 primary applications of the Belmont Report principles?
Informed consent, assessment of risks and benefits, and selection of subjects
Define a clinical trial
A prospective study comparing the effects and value of intervention(s) against a control in human beings
What is an Investigational Medicinal Product (IMP)?
Any drug or micronutrient examined in a clinical trial with the specific purpose of treating, preventing, or diagnosing disease
What is the ideal form of a clinical trial?
Randomized and double-blind
What are the 7 goals of clinical trials?
Treatment, prevention, screening/early detection, diagnosis, prognosis, genetics, and quality of life/supportive care
What is Phase 0 / Microdosing?
First-in-human studies using sub-pharmacological doses (less than 1/100 of active dose, max 100 micrograms) to obtain early pharmacokinetic data
What is the central concept behind microdosing?
"The best model for man is man" — human data is obtained directly rather than extrapolated from animals
How many subjects participate in a Phase 0 study?
10–15 subjects
What is the primary objective of Phase 0 studies?
To obtain preliminary pharmacokinetic data without therapeutic intent
What type of subjects are used in Phase I trials?
15–30 healthy volunteers; patients are used for cytotoxic/anticancer drugs
What is the duration of a Phase I trial?
6–12 months
What does Phase I assess?
Safety, tolerability, pharmacokinetics (primary); pharmacodynamics (secondary)
Define Maximum Tolerated Dose (MTD)
The highest dose of a drug that can be administered before unacceptable toxicity (dose-limiting toxicity) is experienced
How is MTD determined in Phase I?
Dose escalation starting from a low dose; typically 3 patients per dose level; escalation stops when unacceptable toxicity occurs in patients
What is dose-limiting toxicity (DLT)?
The level of toxicity that is unacceptable and determines the upper limit of dosing in Phase I trials
What is Phase II and who participates?
Therapeutic exploratory trial; 50–300 patients who have the disease; tests efficacy and safety
What is the primary objective of Phase II?
To assess drug efficacy in patients; secondary objective is safety
What is the therapeutic window?
The range of drug concentrations that produce a therapeutic response without significant adverse effects
What are Phase III trials?
Large-scale, multicenter, randomized controlled trials (hundreds to 3,000+ patients) to confirm efficacy and safety over up to 5 years
What is Phase IV?
Post-marketing surveillance (PMS) conducted after drug approval to monitor long-term safety and detect rare adverse effects
Give an example of a drug withdrawn after Phase IV findings
Rofecoxib (Vioxx) was withdrawn by Merck on September 30, 2004 due to increased risk of heart attack and stroke with long-term use
What is a parallel design?
A trial design where patients are randomly assigned to one treatment group only and groups run simultaneously
What is a crossover design?
A design where each patient receives both treatments in sequence (AB or BA), with each patient serving as their own control
What is the washout period in a crossover design?
A gap between treatments to eliminate carryover effects from the first treatment before starting the second
Name two diseases suited for crossover design
Asthma and hypertension (chronic, stable conditions with short-term treatment effects)
What is group allocation/cluster randomization?
A design where whole groups (villages, clinics, schools) are randomized instead of individuals
What is a factorial design?
A design that tests two interventions simultaneously; assumes treatments do not interact and have independent modes of action
Give an example of a factorial design trial
ISIS-3 (International Study of Infarct Survival–3): tested 3 fibrinolytics vs. 2 antithrombotic regimens in 41,299 patients
What is a large simple design?
A trial with very large patient numbers, broad eligibility criteria, and minimal data collection to detect modest treatment benefits
What is an equivalence design?
A trial designed to show that a new treatment is equally effective as the existing standard treatment
What is a non-inferiority design?
A trial designed to show that a new treatment is not worse than an established treatment by more than a defined margin
What is a superiority trial?
A trial designed to show that a new intervention is better than the control/existing treatment
What is an adaptive design?
A trial design that allows pre-specified modifications (e.g., sample size, dose, population) based on interim data collected during the study
What must be true for adaptations in adaptive trial designs?
All adaptations must be pre-specified in the protocol before the trial begins; IRB approval must include the adaptation plan
Name two advantages of adaptive designs
Greater flexibility and potentially shorter duration/fewer patients needed
Name two limitations of adaptive designs
Difficult to explain/interpret results and may be hard to implement due to need for quick data access
What is the IND Application?
Investigational New Drug Application submitted to the FDA or EMA requesting approval to begin testing a drug in humans after preclinical studies
What are the phases of clinical trials in order and their focus?
Phase 0: target hitting/PK; Phase I: dose/safety; Phase II: efficacy and safety; Phase III: clinical outcome; Phase IV: long-term post-marketing outcome